Visit COVID-19 resources

[Skip to Content]

Evolving role of anti-VEGF for diabetic macular oedema: from clinical trials to real life – (Eye Journal)

Sep 20
2019

Eye, Published online: 20 September 2019; doi:10.1038/s41433-019-0590-0 Evolving role of anti-VEGF for diabetic macular oedema: from clinical trials to real life

  • 20 September 2019

The perivascular space of the central retinal artery as a potential major cerebrospinal fluid inflow route: implications for optic disc edema in astronauts – (Eye Journal)

Sep 20
2019

Eye, Published online: 20 September 2019; doi:10.1038/s41433-019-0594-9 The perivascular space of the central retinal artery as a potential major cerebrospinal fluid inflow route: implications for optic disc edema in astronauts

  • 20 September 2019

Brolucizimab—leading an era of structural revolution for long-term VEGF suppression – (Eye Journal)

Sep 19
2019

Eye, Published online: 19 September 2019; doi:10.1038/s41433-019-0583-z Brolucizimab—leading an era of structural revolution for long-term VEGF suppression

  • 19 September 2019

Abicipar pegol—a novel anti-VEGF therapy with a long duration of action – (Eye Journal)

Sep 19
2019

Eye, Published online: 19 September 2019; doi:10.1038/s41433-019-0584-y Abicipar pegol—a novel anti-VEGF therapy with a long duration of action

  • 19 September 2019

Circumpapillary and macular vessel density assessment by optical coherence tomography angiography in eyes with temporal hemianopia from chiasmal compression. Correlation with retinal neural and visual field loss – (Eye Journal)

Sep 18
2019

Eye, Published online: 18 September 2019; doi:10.1038/s41433-019-0564-2 Circumpapillary and macular vessel density assessment by optical coherence tomography angiography in eyes with temporal hemianopia from chiasmal compression. Correlation with retinal neural and visual field loss

  • 18 September 2019